AVENIO Millisect System: Optimize Tumor Yield with Precise Dissection
Wednesday, September 16th 2020, 1:00 p.m. ET, 10 a.m. PT
Teri Rambo Mueller, Field Applications Consultant, Roche Sequencing and Life Science;
Daniel Kim, Instrument Sales Specialist, Roche Sequencing and Life Science
In the age of precision medicine, molecular testing by next-generation sequencing and PCR are transforming oncology decision making. The clinical value of that molecular testing is significantly enhanced by precise dissection of formalin-fixed paraffin-embedded tissue samples.
The AVENIO Millisect System is an automated, high-performance FFPE tissue-dissection system that enables the precise and consistent recovery of tissue areas of interest for molecular pathology. Easily integrated into a variety of clinical workflow configurations, the AVENIO Millisect System can help labs efficiently extract more clinically relevant information from every sample. Accurate dissection improves the results of diagnostic testing by reducing false negatives and allowing identification of additional potential therapeutic targets.
In this webinar, we:
- Introduced the AVENIO Millisect System
- Provided a demonstration of the tissue dissection process in action